Skip to main content

Advertisement

Table 1 Follow-up and duration of treatment (over 48 months from treatment initiation)

From: Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

  NIVO (n = 170) NIVO + IPI (n = 177) IPI (n = 167)
Follow-up (months)
 Mean 28.8 30.0 21.7
 Median 35.6 32.2 15.0
Duration of treatment (months)a
 Mean 14.2 10.8 1.8
 Median 5.5 2.5 2.1
  1. NIVO + IPI nivolumab + ipilimumab cohort, NIVO nivolumab monotherapy cohort, IPI ipilimumab monotherapy cohort
  2. aDuration of treatment has been taken to be the period from treatment start to last day of use of a drug